Latest debt-to-equity ratio
Maze Therapeutics Debt-to-equity ratio
Direct answer
Maze Therapeutics's debt-to-equity ratio is 13.34%.
The verified market snapshot reports 13.34%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Maze Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 13.34%
Explore related company data
View Maze Therapeutics's market capitalizationView Maze Therapeutics's price-to-book ratioView Maze Therapeutics's return on equityView Maze Therapeutics's dividend yieldView Maze Therapeutics's 52-week price rangeView Maze Therapeutics's profit marginView all Maze Therapeutics key metricsReturn to Maze Therapeutics profile